Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 51-100 of 1324 result(s).
CYDY CytoDyn Inc
09/01/2025 12:28:08 PM
I will say -- Briefing to the FDA. (4)
CYDY CytoDyn Inc
09/01/2025 10:10:35 AM
MGK, re: your a.m. post today.... " (1)
CYDY CytoDyn Inc
09/01/2025 9:28:20 AM
".....got those records, pulled th (10)
CYDY CytoDyn Inc
08/31/2025 7:32:10 PM
Possible we have agreement / fundin (5)
CYDY CytoDyn Inc
08/31/2025 6:16:59 PM
Multiple shots fired by Dr. J: : Ye (5)
CYDY CytoDyn Inc
08/31/2025 3:13:56 PM
The women who were enrolled in the (12)
CYDY CytoDyn Inc
08/31/2025 8:58:24 AM
Im 50/50 ---- but has alot of publi (2)
CYDY CytoDyn Inc
08/30/2025 10:25:02 PM
According to the American Brain Tum (5)
CYDY CytoDyn Inc
08/30/2025 6:43:37 PM
March letter: * To accelerate progr (6)
CYDY CytoDyn Inc
08/28/2025 11:21:22 PM
Pfizer phase 3 sub-q PD-1 inhibitor (3)
CYDY CytoDyn Inc
08/28/2025 4:50:18 PM
Party poppers better be what he has (2)
CYDY CytoDyn Inc
08/28/2025 11:29:23 AM
Everything on boards are assumption (2)
CYDY CytoDyn Inc
08/28/2025 10:40:40 AM
Real news before Sept. 10th. Mr. Ho (3)
CYDY CytoDyn Inc
08/28/2025 9:55:51 AM
Until the current mgt says one is i (5)
CYDY CytoDyn Inc
08/28/2025 9:42:53 AM
"..that management will participate (1)
CYDY CytoDyn Inc
08/28/2025 9:23:25 AM
Today means Mr. Hoffman has been ac (4)
CYDY CytoDyn Inc
08/28/2025 12:07:51 AM
Here you go USS --- Dr. Lalezari Au (9)
CYDY CytoDyn Inc
08/27/2025 3:51:46 PM
& the Alzheimer’s trial --- who p (6)
CYDY CytoDyn Inc
08/27/2025 1:18:37 PM
Past 3 trials @ 42 patients. Aug. 2 (11)
CYDY CytoDyn Inc
08/27/2025 10:40:42 AM
Follow the info ---- Keytruda for C
CYDY CytoDyn Inc
08/27/2025 10:19:44 AM
100% it's Keytruda..Re-read & Re-li (9)
CYDY CytoDyn Inc
08/27/2025 6:05:21 AM
Screening & Early Detection: LifeTr (5)
CYDY CytoDyn Inc
08/26/2025 9:42:52 PM
Creativ-Bio applying for FDA cancer (5)
CYDY CytoDyn Inc
08/26/2025 5:15:21 AM
Here's our mTNBC ICI's: In a 4-year (7)
CYDY CytoDyn Inc
08/25/2025 11:53:42 PM
April 2020 Dr. J manufacturing path
CYDY CytoDyn Inc
08/25/2025 11:11:51 PM
5/15/2025 De Javu to me... https:// (1)
CYDY CytoDyn Inc
08/25/2025 11:36:52 AM
Thx!...also including if some Compa (2)
CYDY CytoDyn Inc
08/25/2025 11:09:26 AM
To me, before Game Changer validati (4)
CYDY CytoDyn Inc
08/25/2025 10:21:13 AM
Yes sir...good Mgt never compiles a (2)
CYDY CytoDyn Inc
08/25/2025 9:17:07 AM
Funding needs: Based on FDA submiss (8)
CYDY CytoDyn Inc
08/24/2025 8:49:56 PM
5 vs 1. No lung, brain ---- non-tox (9)
CYDY CytoDyn Inc
08/24/2025 1:45:45 PM
Dr. J interview is MORE SIGNIFICANT (16)
CYDY CytoDyn Inc
08/24/2025 8:32:42 AM
Then from your posting link on this (4)
CYDY CytoDyn Inc
08/24/2025 8:13:45 AM
That's the catch --- Dr. J said pat (11)
CYDY CytoDyn Inc
08/24/2025 1:44:29 AM
CytoDyn conducted a Phase II "baske (8)
CYDY CytoDyn Inc
08/24/2025 12:28:05 AM
"GBM": @ this point. Google: *Gliob (10)
CYDY CytoDyn Inc
08/23/2025 2:05:49 AM
Aug. 15th & Aug. 20th. Aug 15th: ht (11)
CYDY CytoDyn Inc
08/22/2025 10:33:57 PM
Organs with specialized barrier sys (6)
CYDY CytoDyn Inc
08/22/2025 10:04:24 PM
Immune Evasion: Cancer cells can di (4)
CYDY CytoDyn Inc
08/22/2025 12:39:35 PM
There isn't a single, readily avail (16)
CYDY CytoDyn Inc
08/22/2025 10:15:37 AM
We're going for the nastiest, harde (9)
CYDY CytoDyn Inc
08/22/2025 10:13:20 AM
'63 Vette split window --- 36 gallo (2)
CYDY CytoDyn Inc
08/22/2025 9:56:15 AM
Glioblastoma possibly being address (16)
CYDY CytoDyn Inc
08/22/2025 9:53:26 AM
" Tony...I identify as Tonya, u tur (3)
CYDY CytoDyn Inc
08/21/2025 1:00:30 PM
May 13th. 2025 "Game Changer": http (8)
CYDY CytoDyn Inc
08/21/2025 9:34:46 AM
No operating BP has ever had a pre- (11)
CYDY CytoDyn Inc
08/21/2025 9:22:45 AM
There we have it. 1 of the Ladies o (10)
CYDY CytoDyn Inc
08/21/2025 3:18:45 AM
PD-L1 monitoring score card after m (6)
CYDY CytoDyn Inc
08/21/2025 12:04:36 AM
Dr. J confirms PD-L1 or PD-1 makes (10)
CYDY CytoDyn Inc
08/20/2025 11:58:49 PM
"...we been working with Cornell as (13)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Exciting Updates from Falcon Oil & Gas on Beetaloo Operations
  • Questerre Energy Advances with PX Acquisition and Partnership
  • Stellantis Welcomes Joao Laranjo as New CFO for Growth
  • Exploring New Insights on Molgramostim for aPAP Patients
  • Finastra Introduces Smart Payment Routing for Financial Firms
  • Innovative Farming Technologies Transforming Lives in Xinjiang
  • Virtual Desktop Infrastructure Market Growth Driven by Trends
  • Anti-Money Laundering Systems Market Forecasts Remarkable Growth
  • Diversified Energy Company Makes Strategic Share Buyback Move
  • Exciting Developments at Tunu Project: Helium Production Potential
  • Falcon Oil & Gas Updates Beetaloo Operations and Future Plans
  • Elis Announces Significant Share Buyback Program Details
  • Recent Share Buyback Highlights for NB Private Equity Partners
  • OSB Group's Share Buyback: Key Insights from Recent Transactions
  • DÉKUPLE Reports Impressive Earnings Amid Strategic Growth Initiatives
  • Jyske Bank Updates Share Repurchase Program in 2025
  • Exploring Foresight Group's Share Buyback Highlights
  • Questerre Partners with Nice Capital to Develop Oil Shale
  • Trifork Group Reports Managerial Transactions and Growth
  • Joao Laranjo Takes the Helm as CFO of Stellantis N.V.
  • Thunes Revolutionizes Global Money Transfers for Banks
  • Discover How inFlow Stockroom Revolutionizes Inventory Management
  • Oracle Innovates with Swift Compatible Payment Solutions
  • Julius Meinl Celebrates International Coffee Day with Excitement
  • NX Belgium Set to Showcase at the Premier Logistics Fair
  • Binggrae to Introduce Korean Delights at Major Food Fair
  • Celebrate the Joy of Coffee: Julius Meinl's Special Day Event
  • Astellas Pharma Revamps Management to Enhance Strategy
  • NX Belgium to Showcase Innovations at Major Logistics Fair
  • Broadridge Enhances Merck's Treasury Operations with Innovation
  • Sampo plc Enhances Shareholder Value with Recent Buybacks
  • Exosens' Major Night Vision Contract with Spanish Defence
  • Exploring Global Water Security at the Great Rivers Forum
  • PayOS and Mastercard Transform Digital Payments with Innovation
  • Nextensa Completes Strategic Sale of Retail Property in Luxembourg
  • Kevin O'Leary Advocates for AI's Role in Job Creation
  • COWI and ISS Join Forces for Enhanced Workplace Services
  • GHO Capital Completes Strategic Sale of VISUfarma to Lupin
  • GHO Capital Completes Sale of VISUfarma to Lupin Limited
  • GHO Capital's Strategic Shift: VISUfarma Joins Lupin's Portfolio
  • Corbion's Share Buyback Program Progress Report Unveiled
  • TGS Initiates Groundbreaking OBN Survey to Enhance Data Intelligence
  • Genmab's Strategic Acquisition: A Leap Towards Innovation
  • Strengthening Workplace Services: ISS and COWI Partner Up
  • Explore the World of Hello Kitty Through a New Mobile Game
  • Tesla's FSD Update: A Game Changer for Multi-Level Parking?
  • Cathie Wood's Insights on Bitcoin vs Ethereum Rivalry
  • Lupin Expands Global Presence in Ophthalmology with VISUfarma
  • RD Technologies Group Elevates Its Payment Solutions with OristaPay
  • TCL Celebrates Olympic Spirit with Team Ambassadors at IFA
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site